Attention-deficit/hyperactivity disorder (ADHD) and behavioral disorders are 2 of the most common mental health diagnoses in child adolescent patients. Many patients seeking treatment for these will initially present to a primary care provider (PCP). PCPs need be able identify ADHD or with thorough history, possibly aided by screening tool. Pharmacologic interventions considered first-line ADHD...

Background: Attention deficit hyperactivity disorder (ADHD) is one of the most frequent behavioral disorders diagnosed in childhood, causing damage to child's neurocognitive development.

LEARNING OBJECTIVES After participating in this activity, learners should be better able to:• Evaluate pharmacologic treatment of attention deficit/hyperactivity disorder (ADHD) in patients with substance use disorder (SUD) • Assess the causes of the diminished efficacy of ADHD medication in patients with comorbid SUD OBJECTIVE: Substance use disorder (SUD) and attention-deficit/hyperactivity d...

background attention deficit hyperactivity disorder (adhd) is a multi-factorial disorder that has defined by hyperactivity, impulsivity and attention deficits. various neurotransmitters such as dopamine can play a role in its pathophysiology. the aim of this study was to examine the association of two common single nucleotide polymorphisms in drd2 gene, taq i a (t/c) and taq i b (g/a), with adh...

The objective of this study was to examine the relation between the 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene and behaviors related to attention- deficit/hyperactivity disorder (ADHD) in individuals with myelomeningocele. The rationale for the study was twofold: folate metabolizing genes, (e.g. MTHFR), are important not only in the etiology of neural tube defects but are also criti...